nitroglycerin has been researched along with naproxen-n-butyl nitrate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cirino, G; Lovren, F; McKnight, W; Muscará, MN; Triggle, CR; Wallace, JL | 1 |
Berndt, G; Grosser, N; Hoogstraate, J; Schröder, H | 1 |
Adding, LC; Agvald, P; Andersson, LI; Gustafsson, LE; Hoogstraate, J; Jonzon, B | 1 |
3 other study(ies) available for nitroglycerin and naproxen-n-butyl nitrate
Article | Year |
---|---|
Antihypertensive properties of a nitric oxide-releasing naproxen derivative in two-kidney, one-clip rats.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Endothelin-1; Hypertension, Renovascular; In Vitro Techniques; Isometric Contraction; Male; Muscle, Smooth, Vascular; Naproxen; Nitrates; Nitric Oxide Donors; Nitrites; Nitroglycerin; Nitroprusside; Phenylephrine; Rats; Rats, Wistar; Renal Artery; Thromboxane B2 | 2000 |
A common pathway of nitric oxide release from AZD3582 and glyceryl trinitrate.
Topics: Animals; Cyclic GMP; Cyclooxygenase Inhibitors; LLC-PK1 Cells; Molsidomine; Naphthalenes; Naproxen; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Swine | 2004 |
Direct gas measurements indicate that the novel cyclooxygenase inhibitor AZD3582 is an effective nitric oxide donor in vivo.
Topics: Acid-Base Equilibrium; Air; Animals; Blood Pressure; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Gases; Heart Rate; Hemoglobins; In Vitro Techniques; Male; Naphthalenes; Naproxen; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroglycerin; Prostaglandin-Endoperoxide Synthases; Rabbits; Vasodilator Agents | 2005 |